Structure-activity relationship and crystallographic analyses of non-secosteroidal vitamin D receptor ligands bearing diphenylsilane core as a hydrophobic pharmacophore.
Mudiyanselage, H.N.T.N., Misawa, T., Ochiai, K., Demizu, Y., Hanazono, Y., Ito, N., Fujii, S.(2025) Bioorg Med Chem 128: 118261-118261
- PubMed: 40494220 
- DOI: https://doi.org/10.1016/j.bmc.2025.118261
- Primary Citation of Related Structures:  
9M10, 9M11, 9M12, 9M13, 9M14, 9M15, 9M16, 9M17, 9M18, 9M19, 9M1A, 9M1B, 9M1C, 9M1D - PubMed Abstract: 
Vitamin D receptor (VDR) is an attractive target of drug discovery for multiple diseases. In this study, we systematically designed and synthesized a series of diphenylsilane derivatives with diverse hydrophobic substituents and investigated their structure-activity relationship (SAR) as VDR agonists. The SAR study revealed that the activity is dependent on the type of substituent and the position of substitution, and the diethyl-di-m-tolylsilane scaffold was identified as the most suitable hydrophobic core structure of this type of VDR ligands. Interestingly, the small structural difference between n-propyl and allyl substituents resulted in a large difference in the activity. Comparison of the co-crystal structures of 14 diphenylsilane compounds, including less potent compounds, bound to the rat VDR ligand-binding domain suggested that the differences in activity are due to a combination of factors, including differences in hydrophilic and hydrophobic interactions, and ligand conformations.
- Laboratory for Biomaterials and Bioengineering, Institute of Integrated Research, Institute of Science Tokyo, 2-3-10 Kanda-Surugadai, Chiyoda-ku, Tokyo 101-0062, Japan; Medical Research Laboratory, Institute of Integrated Research, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan.
Organizational Affiliation: